{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T23:01:40Z","timestamp":1793142100277,"version":"4.5.0"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T00:00:00Z","timestamp":1751241600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Asian Journal of Psychiatry"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.ajp.2025.104604","type":"journal-article","created":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T19:59:02Z","timestamp":1750967942000},"page":"104604","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Treatment approaches and efficacy in psychedelic-induced psychosis: A systematic review"],"prefix":"10.1016","volume":"110","author":[{"given":"Adi","family":"Sulstarova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luise","family":"Scheuerlein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Monari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Seragnoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thorens","family":"Gabriel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrin","family":"Preller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerem","family":"B\u00f6ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Othman","family":"Sentissi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Kaiser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Solmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Kirschner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8530-5596","authenticated-orcid":false,"given":"Michel","family":"Sab\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajp.2025.104604_bib1","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1176\/ajp.140.4.456","article-title":"L-5-hydroxytryptophan for LSD-induced psychosis","volume":"140","author":"Abraham","year":"1983","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.ajp.2025.104604_bib2","doi-asserted-by":"crossref","DOI":"10.1097\/00004714-199606000-00008","article-title":"LSD-like panic from risperidone in post-LSD visual disorder","volume":"16","author":"Abraham","year":"1996","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.ajp.2025.104604_bib3","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1176\/appi.psychotherapy.1966.20.3.415","article-title":"LSD in psychotherapy and alcoholism","volume":"20","author":"Abramson","year":"1966","journal-title":"Am. J. Psychother."},{"issue":"2-3","key":"10.1016\/j.ajp.2025.104604_bib4","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/S0165-0173(99)00046-6","article-title":"Serotonin model of schizophrenia: emerging role of glutamate mechanisms","volume":"31","author":"Aghajanian","year":"2000","journal-title":"Brain Res. Brain Res. Rev."},{"key":"10.1016\/j.ajp.2025.104604_bib5","doi-asserted-by":"crossref","unstructured":"APA, 2022. Diagnostic And Statistical Manual Of Mental Disorders, Fifth Edition, 5th ed. https:\/\/doi.org\/10.1176\/appi.books.9780890425787.","DOI":"10.1176\/appi.books.9780890425787"},{"key":"10.1016\/j.ajp.2025.104604_bib6","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0893-133X(01)00230-5","article-title":"Continuous phencyclidine treatment induces schizophrenia-like hyperreactivity of striatal dopamine release","volume":"25","author":"Balla","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ajp.2025.104604_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajem.2020.04.090","article-title":"N,N-Dimethyltryptamine: DMT-induced psychosis","author":"Barbic","year":"2020","journal-title":"Am. J. Emerg. Med."},{"key":"10.1016\/j.ajp.2025.104604_bib8","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1093\/schbul\/16.1.81","article-title":"Psychotogenic drug use and neuroleptic response","volume":"16","author":"Bowers","year":"1990","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.ajp.2025.104604_bib9","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.brainresbull.2016.04.016","article-title":"Neuropharmacology of N,N-dimethyltryptamine","volume":"126","author":"Carbonaro","year":"2016","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.ajp.2025.104604_bib10","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1124\/jpet.105.092304","article-title":"Depressive-like effects of the kappa-opioid receptor agonist salvinorin A on behavior and neurochemistry in rats","volume":"316","author":"Carlezon","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ajp.2025.104604_bib11","article-title":"Ayahuasca-induced psychosis: a case report","author":"Cer\u00f3n Tapia","year":"2021","journal-title":"Rev. Colomb. Psiquiatr. (Engl. Ed.)."},{"key":"10.1016\/j.ajp.2025.104604_bib12","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17111953","article-title":"d-Lysergic acid diethylamide (LSD) as a model of psychosis: mechanism of action and pharmacology","volume":"17","author":"De Gregorio","year":"2016","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.ajp.2025.104604_bib13","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/00007691-200404000-00009","article-title":"Human pharmacology of MDMA: pharmacokinetics, metabolism, and disposition","volume":"26","author":"de la Torre","year":"2004","journal-title":"Ther. Drug Monit."},{"issue":"4","key":"10.1016\/j.ajp.2025.104604_bib14","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1080\/02791072.2015.1073815","article-title":"The association of salvia divinorum and psychotic disorders: a review of the literature and case series","volume":"47","author":"El-Khoury","year":"2015","journal-title":"J. Psychoact. Drugs"},{"key":"10.1016\/j.ajp.2025.104604_bib15","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1001\/archpsyc.1966.01730170002002","article-title":"Prolonged adverse reactions to LSD in psychotic subjects","volume":"15","author":"Fink","year":"1966","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.ajp.2025.104604_bib16","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2021.694863","article-title":"Substance-induced psychoses: an updated literature review","volume":"12","author":"Fiorentini","year":"2021","journal-title":"Front. Psychiatry"},{"issue":"127","key":"10.1016\/j.ajp.2025.104604_bib17","first-page":"129","article-title":"Case report: an ingestion of Hawaiian Baby Woodrose seeds associated with acute psychosis","volume":"62","author":"Gertsch","year":"2003","journal-title":"Hawaii Med. J."},{"key":"10.1016\/j.ajp.2025.104604_bib18","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0024-3205(98)00262-8","article-title":"Lysergic acid diethylamide (LSD) is a partial agonist of D2 dopaminergic receptors and it potentiates dopamine-mediated prolactin secretion in lactotrophs in vitro","volume":"63","author":"Giacomelli","year":"1998","journal-title":"Life Sci."},{"key":"10.1016\/j.ajp.2025.104604_bib19","doi-asserted-by":"crossref","first-page":"573","DOI":"10.3109\/15563658408992586","article-title":"Comparison of chlorpromazine, haloperidol and pimozide in the treatment of phencyclidine psychosis: DA-2 receptor specificity","volume":"22","author":"Giannini","year":"1984","journal-title":"J. Toxicol. Clin. Toxicol."},{"key":"10.1016\/j.ajp.2025.104604_bib20","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1001\/archpsyc.1970.01750020001001","article-title":"Chronic psychosis associated with long-term psychotomimetic drug abuse","volume":"23","author":"Glass","year":"1970","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.ajp.2025.104604_bib21","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0099-9598(01)56006-X","article-title":"Chapter 2 Mechanisms of action of ibogaine: relevance to putative therapeutic effects and development of a safer iboga alkaloid congener","volume":"56","author":"Glick","year":"2001","journal-title":"Alkaloids Chem. Biol."},{"key":"10.1016\/j.ajp.2025.104604_bib22","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1080\/08039480252803927","article-title":"Three cases of angel\u2019s trumpet tea-induced psychosis in adolescent substance abusers","volume":"56","author":"G\u00f6pel","year":"2002","journal-title":"Nord. J. Psychiatry"},{"key":"10.1016\/j.ajp.2025.104604_bib23","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: An emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.ajp.2025.104604_bib24","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1177\/0269881110388326","article-title":"Differential contributions of serotonin receptors to the behavioral effects of indoleamine hallucinogens in mice","volume":"25","author":"Halberstadt","year":"2011","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.ajp.2025.104604_bib25","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/S0140-6736(70)90220-5","article-title":"Delayed Psychosis Due to L.S.D","volume":"296","author":"Hatrick","year":"1970","journal-title":"Lancet"},{"key":"10.1016\/j.ajp.2025.104604_bib26","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1192\/bjp.132.6.602","article-title":"Abuse of indigenous psilocybin mushrooms: a new fashion and some psychiatric complications","volume":"132","author":"Hyde","year":"1978","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.ajp.2025.104604_bib27","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.neuropharm.2014.07.016","article-title":"Salvinorin A regulates dopamine transporter function via a kappa opioid receptor and ERK1\/2-dependent mechanism","volume":"86","author":"Kivell","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ajp.2025.104604_bib28","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1159\/000059383","article-title":"Ecstasy-induced psychotic disorder: six-month follow-up study","volume":"8","author":"Landabaso","year":"2002","journal-title":"Eur. Addict. Res."},{"key":"10.1016\/j.ajp.2025.104604_bib29","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/1099-1077(200006)15:4<301::AID-HUP168>3.0.CO;2-#","article-title":"Risperidone as an antidote to hallucinogenics -should it be prescribed?","volume":"15","author":"Lauerma","year":"2000","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.ajp.2025.104604_bib30","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1001\/jamapsychiatry.2021.2130","article-title":"Examination of dosing of antipsychotic drugs for relapse prevention in patients with stable schizophrenia: a meta-analysis","volume":"78","author":"Leucht","year":"2021","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.ajp.2025.104604_bib31","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0924-977X(00)00086-9","article-title":"Acute psychological and physiological effects of MDMA (\u201cEcstasy\u201d) after haloperidol pretreatment in healthy humans","volume":"10","author":"Liechti","year":"2000","journal-title":"Eur. Neuropsychopharmacol. J. Eur. Coll. Neuropsychopharmacol."},{"key":"10.1016\/j.ajp.2025.104604_bib32","doi-asserted-by":"crossref","DOI":"10.7759\/cureus.59641","article-title":"Navigating treatment challenges: a case study on refractory psychosis in a chronic MDMA (3,4-Methylenedioxymethamphetamine) user","author":"Litenski","year":"2024","journal-title":"Cureus"},{"key":"10.1016\/j.ajp.2025.104604_bib33","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1080\/15622970701459828","article-title":"Obsessive-compulsive disorder followed by psychotic episode in long-term ecstasy misuse","volume":"10","author":"Marchesi","year":"2009","journal-title":"World J. Biol. Psychiatry Off. J. World Fed. Soc. Biol. Psychiatry"},{"key":"10.1016\/j.ajp.2025.104604_bib34","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1749-6632.1998.tb08242.x","article-title":"Medication development of ibogaine as a pharmacotherapy for drug dependence","volume":"844","author":"Mash","year":"1998","journal-title":"Ann. N Y Acad. Sci."},{"key":"10.1016\/j.ajp.2025.104604_bib35","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1136\/bmj.302.6778.697","article-title":"Chronic paranoid psychosis after misuse of MDMA (' \u201cecstasy\u201d\u2019)","volume":"302","author":"McGuire","year":"1991","journal-title":"Br. Med. J."},{"key":"10.1016\/j.ajp.2025.104604_bib36","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1176\/ajp.128.3.351","article-title":"ECT in LSD psychosis. a report of three cases","volume":"128","author":"Muller","year":"1971","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.ajp.2025.104604_bib37","first-page":"264","article-title":"Psychedelics","author":"Nichols","year":"2016"},{"key":"10.1016\/j.ajp.2025.104604_bib38","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1556\/2054.2018.009","article-title":"The influence of therapists\u2019 first-hand experience with psychedelics on psychedelic-assisted psychotherapy research and therapist training","volume":"2","author":"Nielson","year":"2018","journal-title":"J. Psychedelic Stud."},{"key":"10.1016\/j.ajp.2025.104604_bib39","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1080\/15622970701870933","article-title":"Hippocampal remodelling after MDMA neurotoxicity: a single case study","volume":"10","author":"Nifos\u00ec","year":"2009","journal-title":"World J. Biol. Psychiatry Off. J. World Fed. Soc. Biol. Psychiatry"},{"key":"10.1016\/j.ajp.2025.104604_bib40","first-page":"366","article-title":"Die klinische Therapie seelischer St\u00f6rungen mit Lysergs\u00e4ure","volume":"15","author":"Opitz","year":"1963","journal-title":"Psychiatr. Neurol. Med. Psychol."},{"key":"10.1016\/j.ajp.2025.104604_bib41","doi-asserted-by":"crossref","first-page":"240","DOI":"10.3389\/fpsyt.2017.00240","article-title":"The \u201cEndless Trip\u201d among the NPS users: psychopathology and psychopharmacology in the hallucinogen-persisting perception disorder. A systematic review","volume":"8","author":"Orsolini","year":"2017","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.ajp.2025.104604_bib42","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.rcp.2019.10.005","article-title":"Psychosis induced by abuse of ayahuasca: a case report","volume":"50","author":"Palma-\u00c1lvarez","year":"2021","journal-title":"Rev. Colomb. Psiquiatr"},{"key":"10.1016\/j.ajp.2025.104604_bib43","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/WNF.0000000000000078","article-title":"N,N-Dimethyltryptamine-Induced Psychosis","volume":"38","author":"Paterson","year":"2015","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.ajp.2025.104604_bib44","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1080\/00048679509075930","article-title":"Catatonia LSD induced?","volume":"29","author":"Perera","year":"1995","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"10.1016\/j.ajp.2025.104604_bib45","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.euroneuro.2023.07.011","article-title":"Psilocybin-assisted therapy for depression: a systematic review and dose-response meta-analysis of human studies","volume":"76","author":"Perez","year":"2023","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.ajp.2025.104604_bib46","article-title":"Ethanol and phencyclidine interact with respect to nucleus accumbens dopamine release: differential effects of administration order and pretreatment protocol","volume":"4","author":"Pickering","year":"2010","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.ajp.2025.104604_bib47","unstructured":"Potash, M.N., Gordon, K.A., Conrad, K.L., 2009. Persistent Psychosis and Medical Complications After a Single Ingestion of MDMA \u201cEcstasy\u201d: A Case Report and Review of the Literature. Psychiatry (Edgmont)."},{"key":"10.1016\/j.ajp.2025.104604_bib48","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0893-133X(88)90001-2","article-title":"Potency of antipsychotics in reversing the effects of a hallucinogenic drug on locus coeruleus neurons correlates with 5-HT2 binding affinity","volume":"1","author":"Rasmussen","year":"1988","journal-title":"Neuropsychopharmacol. Off. Publ. Am. Coll. Neuropsychopharmacol."},{"key":"10.1016\/j.ajp.2025.104604_bib49","doi-asserted-by":"crossref","DOI":"10.3390\/healthcare12030339","article-title":"Third-generation antipsychotics and lurasidone in the treatment of substance-induced psychoses: a narrative review","volume":"12","author":"Ricci","year":"2024","journal-title":"Healthcare"},{"key":"10.1016\/j.ajp.2025.104604_bib50","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.neuropharm.2015.08.034","article-title":"Receptor interaction profiles of novel N-2-methoxybenzyl (NBOMe) derivatives of 2,5-dimethoxy-substituted phenethylamines (2C drugs)","volume":"99","author":"Rickli","year":"2015","journal-title":"Neuropharmacology"},{"issue":"5","key":"10.1016\/j.ajp.2025.104604_bib51","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1176\/appi.ajp.20230172","article-title":"Psychedelics as Transformative Therapeutics","volume":"180","author":"Roth","year":"2023","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.ajp.2025.104604_bib52","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/1098-2396(20010101)39:1<32::AID-SYN5>3.0.CO;2-3","article-title":"Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin","volume":"39","author":"Rothman","year":"2001","journal-title":"Synapse"},{"key":"10.1016\/j.ajp.2025.104604_bib53","article-title":"Reconsidering evidence for psychedelic-induced psychosis: an overview of reviews, a systematic review, and meta-analysis of human studies","author":"Sab\u00e9","year":"2024","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.ajp.2025.104604_bib54","first-page":"407","article-title":"Reversibility of induced psychosis with chlorpromazine","volume":"30","author":"Schwarz","year":"1955","journal-title":"Proc. Staff Meet. Mayo Clin."},{"key":"10.1016\/j.ajp.2025.104604_bib55","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1177\/1363461510378469","article-title":"Raves, psychosis, and spirit healing","volume":"47","author":"Seeman","year":"2010","journal-title":"Transcult. Psychiatry"},{"issue":"11","key":"10.1016\/j.ajp.2025.104604_bib56","doi-asserted-by":"crossref","first-page":"4376","DOI":"10.1073\/pnas.72.11.4376","article-title":"Brain receptors for antipsychotic drugs and dopamine: direct binding assays","volume":"72","author":"Seeman","year":"1975","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.ajp.2025.104604_bib57","doi-asserted-by":"crossref","first-page":"3513","DOI":"10.1073\/pnas.0409766102","article-title":"Dopamine supersensitivity correlates with D2High states, implying many paths to psychosis","volume":"102","author":"Seeman","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ajp.2025.104604_bib58","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1177\/026988119400800110","article-title":"Psychiatric complications of \u201cEcstasy\u201d use","volume":"8","author":"Series","year":"1994","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.ajp.2025.104604_bib59","unstructured":"Shannon, M.W., Borron, S.W., Burns, M.J., 2007. Haddad and Winchester\u2019s Clinical Management of Poisoning and Drug Overdose (4th edition)."},{"key":"10.1016\/j.ajp.2025.104604_bib60","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1024\/1422-4917\/a000792","article-title":"Herbal High: Substanzinduzierte Psychose nach dem Konsum von Samen der Hawaiianischen Holzrose","volume":"49","author":"Sobanski","year":"2021","journal-title":"Z. Kinder Jugend Psychother."},{"key":"10.1016\/j.ajp.2025.104604_bib61","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.euroneuro.2022.09.004","article-title":"A century of research on psychedelics: a scientometric analysis on trends and knowledge maps of hallucinogens, entactogens, entheogens and dissociative drugs","volume":"64","author":"Solmi","year":"2022","journal-title":"Eur. Neuropsychopharmacol. J. Eur. Coll. Neuropsychopharmacol."},{"key":"10.1016\/j.ajp.2025.104604_bib62","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1097\/00005053-198410000-00001","article-title":"Adverse reactions to psychedelic drugs. A review of the literature","volume":"172","author":"Strassman","year":"1984","journal-title":"J. Nerv. Ment. Dis."},{"key":"10.1016\/j.ajp.2025.104604_bib63","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1097\/NMD.0000000000001489","article-title":"From mushrooms to myolysis: a case of rhabdo in psilocybin-induced mood and psychotic disorder","volume":"210","author":"Suleiman","year":"2022","journal-title":"J. Nerv. Ment. Dis."},{"key":"10.1016\/j.ajp.2025.104604_bib64","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1080\/02791072.2001.10400473","article-title":"An \u201caccidental\u201d acute psychosis with ecstasy use","volume":"33","author":"Vaiva","year":"2001","journal-title":"J. Psychoact. Drugs"},{"key":"10.1016\/j.ajp.2025.104604_bib65","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1176\/appi.psy.42.6.525","article-title":"Persistent psychosis after a single ingestion of \u201cecstasy\u201d","volume":"42","author":"Van Kampen","year":"2001","journal-title":"Psychosomatics"},{"key":"10.1016\/j.ajp.2025.104604_bib66","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1177\/02698811030173018","article-title":"Neuropsychiatric consequences (atypical psychosis and complex-partial seizures) of ecstasy use: possible evidence for toxicity-vulnerability predictors and implications for preventative and clinical care","volume":"17","author":"Vecellio","year":"2003","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.ajp.2025.104604_bib67","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/1032638","article-title":"Biological effects and biodistribution of bufotenine on mice","volume":"2018","author":"Vigerelli","year":"2018","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.ajp.2025.104604_bib68","doi-asserted-by":"crossref","DOI":"10.7759\/cureus.3058","article-title":"Persistent psychosis due to single dose of ecstasy","author":"Virani","year":"2018","journal-title":"Cureus"},{"key":"10.1016\/j.ajp.2025.104604_bib69","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.675768","article-title":"On perception and consciousness in HPPD: a systematic review","volume":"15","author":"Vis","year":"2021","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.ajp.2025.104604_bib70","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/nrn2884","article-title":"The neurobiology of psychedelic drugs: implications for the treatment of mood disorders","volume":"11","author":"Vollenweider","year":"2010","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.ajp.2025.104604_bib71","doi-asserted-by":"crossref","DOI":"10.1097\/00001756-199812010-00024","article-title":"Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action","volume":"9","author":"Vollenweider","year":"1998","journal-title":"Neuroreport"},{"key":"10.1016\/j.ajp.2025.104604_bib72","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/BF02942900","article-title":"M.D.M.A. (\u201cEcstasy\u201d); a case of possible drug-induced psychosis","volume":"162","author":"Williams","year":"1993","journal-title":"Ir. J. Med. Sci."},{"issue":"12","key":"10.1016\/j.ajp.2025.104604_bib73","doi-asserted-by":"crossref","first-page":"6713","DOI":"10.3390\/ijms23126713","article-title":"Effect of Psilocybin and Ketamine on Brain Neurotransmitters, Glutamate Receptors, DNA and Rat Behavior","volume":"23","author":"Wojtas","year":"2022","journal-title":"Int. J. Mol. Sci."}],"container-title":["Asian Journal of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876201825002473?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876201825002473?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T08:10:28Z","timestamp":1767773428000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1876201825002473"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":73,"alternative-id":["S1876201825002473"],"URL":"https:\/\/doi.org\/10.1016\/j.ajp.2025.104604","relation":{},"ISSN":["1876-2018"],"issn-type":[{"value":"1876-2018","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment approaches and efficacy in psychedelic-induced psychosis: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Asian Journal of Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajp.2025.104604","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104604"}}